Assessment of the genotoxicity and pro-oxidative potentials of risperidone in L929 murine fibroblasts
- 23 March 2026
- journal article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 89 (20) , 1-11
Abstract
Risperidone is an atypical antipsychotic drug clinically used to treat mood disorders, autism, and schizophrenia. Since risperidone is typically prescribed chronically for clinical use, it is important to determine potential side effects, such as toxicogenic consequences, which remain under-explored for this class of drugs. The main goal of this study was to (1) examine the genotoxicity attributed to risperidone using L929 murine fibroblasts with different standardized techniques (MTT, comet, and micronucleus (MN) assays) and (2) and oxidative potential by measuring levels of reduced glutathione (GSH) and carbonyl proteins, oxidative indices. Data demonstrated that risperidone exhibited a cytotoxic effect after 24 hr exposure, reducing cell viability by approximately 23% (compared to negative controls) at the highest concentration (500 µM). Standard alkaline comet (pH > 13) and MN assays noted the absence of genotoxic/mutagenic potentials after treatment with risperidone (100 and 500 µM), even in the presence of an exogenous metabolizing source (S9 fraction). However, the comet assay displayed the presence of the enzyme formamidopyrimidine DNA-glycosylase (FPG) in cells exposed to 500 µM risperidone resulting in a significant increase in levels of DNA damage, indicative of oxidative damage to the genome. This oxidative DNA damage was corroborated by reduction of the glutathione (GSH) levels, through modulation of GSH-dependent enzymes, and elevated levels of protein oxidation in cultures exposed to 500 µM risperidone. Data demonstrated that 500 µM risperidone exerted a cytotoxic effect on L929 cells accompanied by induction of DNA strand breaks generation of oxidative stress.Keywords
This publication has 35 references indexed in Scilit:
- Antipsychotics Induced Reproductive Toxicity by Stimulating Oxidative Stress: A Comparative in Vivo and in Silico StudyChemistry & Biodiversity, 2023
- Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 UpdateDrugs & Aging, 2022
- Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychoticsNeuroscience Letters, 2010
- Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functionsEuropean Archives of Psychiatry and Clinical Neuroscience, 2009
- Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic targetInternational Journal of Cancer, 2009
- Antipsychotic-induced oxidative stress in Rat BrainNeurotoxicity Research, 2008
- Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brainJournal of Psychiatric Research, 2007
- Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroupMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2007
- Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the ratPsychopharmacology, 1994
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983